Clinical Trial 55455

Santa Maria, CA 93454


The main purpose of this study is to evaluate the effect of efavaleukin alfa on induction of clinical remission in participants with moderately to severely active ulcerative colitis (UC).


To join this study, participants must have been diagnosed with moderate to severe ulcerative colitis (UC) at least 3 months ago and should have tried at least one standard treatment without enough improvement or had issues tolerating it.

However, people with other types of bowel conditions like Crohn's disease, undefined inflammatory bowel disease, or those who have had major surgery for UC, or might need such surgery during the study period, cannot participate.

Qualified Participants May Receive:

Compensation will be provided for qualified participants: $1,500.00 ($50 per visit) 

Available At:

FOMAT Medical Research
361 Town Center West
Suite 101
Santa Maria, CA 93454
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.